Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 14/20 | 0.35 |
| ▸ | CNR1 | P21554 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | KDM1A | O60341 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5079046 | 1.00 | CNR2 (0.35) | CNR2CNR1HPGDOPRL1HTR1A | |
| SCHEMBL2545570 | 0.88 | USP30 (0.37) | CNR2CNR1OPRL1HTR1ASLC6A2 | |
| SCHEMBL2545568 | 0.88 | USP30 (0.37) | CNR2CNR1OPRL1HTR1ASLC6A2 | |
| SCHEMBL3911932 | 0.87 | OPRL1 (0.32) | CNR2CNR1HPGDOPRL1KDM1A | |
| SCHEMBL3911928 | 0.87 | OPRL1 (0.32) | CNR2CNR1HPGDOPRL1KDM1A | |
| SCHEMBL4320971 | 0.87 | HPGD (0.33) | CNR2CNR1HPGDHTR1ASLC6A2 | |
| SCHEMBL15803731 | 0.87 | HPGD (0.35) | CNR2CNR1HPGDOPRL1KDM1A | |
| SCHEMBL11940767 | 0.86 | OPRL1 (0.32) | CNR2CNR1HPGDOPRL1KDM1A | |
| SCHEMBL18134228 | 0.85 | CYP2C9 (0.38) | OPRL1KDM1A | |
| SCHEMBL12733782 | 0.85 | CYP2C9 (0.38) | OPRL1KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8580146-B2 | Liquid crystal compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2013-11-12 | — | — | US | disclosed |
| US-20120193577-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2012-08-02 | — | — | US | disclosed |
| EP-1362839-B1 | Liquid crystal composition having a positive delta-epsilon and liquid crystal display device | CHISSO CORP (JP) | 2008-08-13 | — | — | EP | disclosed |
| US-7081279-B2 | Alkenyl compound having a negative Δε value, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2006-07-25 | — | — | US | disclosed |
| US-20040065866-A1 | Alkenyl compound having a negative delta epsilon value, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2004-04-08 | — | — | US | disclosed |
| US-6692657-B1 | ALKENYL COMPOUND WITH 2,3-DIFLUOROPHENYL GROUP | CHISSO CORPORATION (JP) | 2004-02-17 | — | — | US | disclosed |
| EP-1362839-A2 | Liquid crystal composition having a delta-epsilon- of not less than zero and liquid crystal display device | CHISSO CORPORATION (JP) | 2003-11-19 | — | — | EP | disclosed |
| EP-0969071-B1 | Alkenyl compound having a negative delta epsilon value, liquid crystal composition and liquid crystal display device | CHISSO CORP (JP) | 2003-11-05 | — | — | EP | disclosed |
| EP-0969071-A1 | Alkenyl compound having a negative delta epsilon value, liquid crystal composition and liquid crystal display device | CHISSO CORPORATION (JP) | 2000-01-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120193577-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | KIF23, MARK3, CCND3 | CNR2 1611/4885CNR1 1832/4885HPGD 4155/4885 |
| US-20040065866-A1 | Alkenyl compound having a negative delta epsilon value, liquid crystal composition, and liquid crystal display device | CTNND1, CCT4, DLK1 | CNR2 2495/4885CNR1 1906/4885HPGD 3992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.